Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Predictions of the incidence of gastrointestinal cancers in the Świętokrzyskie region by the year 2025
 
More details
Hide details
 
Submission date: 2018-02-24
 
 
Final revision date: 2018-09-09
 
 
Acceptance date: 2018-12-07
 
 
Publication date: 2019-03-30
 
 
Medical Studies 2019;35(1):32-40
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Malignant tumours are a growing health problem in Polish society. The authors have made an attempt to estimate the incidence of tumours of digestive organs in the future – among others, colorectal cancer, constituting 17.4% of cases in men and 10.0% among women. The above assessment is important for administrative reasons (allocation of resources, e.g. between prevention, diagnosis, treatment, social assistance) and scientific (evaluation of the effectiveness of interventions).

Aim of the research:
To forecast the incidence of selected gastrointestinal cancers in the Świętokrzyskie region by the year 2025.

Material and methods:
The research material consisted of the data concerning 13,002 incidences of gastrointestinal cancers in the Świętokrzyskie region in the period from 1999 to 2014 produced by the National Cancer Registry. The Hakulinen and Dyba method developed by the Finnish Cancer Registry was used to estimate the expected morbidity and incidence rates in the period of 10 years.

Results:
The rate of the expected morbidity and incidence rates in 2025 compared to 2014 is presented for stomach, colon, rectum, and liver cancers in men and women.

Conclusions:
The predictions in terms of the incidence of cancers, including rectum and liver cancers in men as well as colon and rectum cancers in women, in the Świętokrzyskie region indicate an upward trend compared to the year 2014. A downward trend in morbidity refers to stomach and colon cancers in men as well as stomach and liver cancers in women.
REFERENCES (16)
1.
Didkowska J, Wojciechowska U, Olasek P. Nowotwory złośliwe w Polsce w 2015 roku. Ministerstwo Zdrowia, Warszawa 2017.
 
2.
Wojciechowska U, Olasek P, Czauderna K, Didkowska J. Nowotwory złośliwe w Polsce w 2014 roku. Ministerstwo Zdrowia, Warszawa 2016.
 
3.
www.onkologia.org.pl.
 
4.
Zatoński W, Sulkowska U, Przewoźniak K, Zatoński M. Epidemiologia nowotworów złośliwych w Polsce. In: Zachorowalność i umieralność na nowotwory a sytuacja demograficzna Polski. Potrykowska A, Strzelecki Z, Szymborski J, Witkowski J (eds). Rządowa Rada Ludnościowa, Warsaw 2014.
 
5.
Boyle P, Autier P, Bartelnik H, Baselga J, Boffetta P, Burn HJ, Burns HJG, Denis L, Dicato M, Diehl V, Doll R, Franceschi S, Gillis CR, Gray N, Griciute L, Hackshaw A, Kasler M, Kogevinas M, Kvinnsland S, La Vecchia C, Levi F, McVie JG, Maisonneuve P, Martin-Moreno JM, Newton Bishop J, Oleari F, Perrin P, Quinn M, Richards M, Ringborg U, Scully C, Siracka E, Storm H, Tubiana M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze DG, Zatoński W, zur Hausen H. Europejski kodeks walki z rakiem 2003. Zatoński W (ed.). Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Warsaw 2009.
 
6.
World Health Organization (WHO) Regional Office for Europe, Review of Social Determinants and the Health Divide in the WHO European Region. Final Report. Marmot M (Zatoński W. Współautor raportu i przewodniczący grupy roboczej “Ill health prevention and treatment”). WHO Regional Office for Europe, UCL Institute of Health Equity, Kopenhaga, Dania 2013.
 
7.
Didkowska J, Wojciechowska U, Zatoński W. Prognozy zachorowalności i umieralności na nowotwory złośliwe w Polsce do 2025 roku. Krajowy Rejestr Nowotworów, Warsaw 2009.
 
8.
Hakulinen T, Dyba T. Precisin of incidence predictions based on poisson distributed observations. Stat Med 1994; 13: 1513-1523.
 
9.
Zatoński W, Przewoźniak K. Ograniczanie zachorowalności i umieralności z powodu chorób nowotworowych. In: Zdrowie Publiczne i Polityka Ludnościowa. Vol. II. Szymborski J (ed.). Rządowa Rada Ludnościowa, Warsaw 2012; 78-89.
 
10.
Robins G, Crabtree JE, Bailey A, Forman D. International variation in Helicobacter pylori infection and rates of esophageal cancer. Eur J Cancer 2008; 44: 726-732.
 
11.
Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatoński W, Chanock S, Morabia A, Chow WH. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 115-121.
 
12.
Zhang FF, Hou L, Terry MB, Lissowska J, Morabia A, Chen J, Yeager M, Zatoński W, Chanock S, Chow WH. Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland. Int J Cancer 2007; 121: 2060-2064.
 
13.
Onkologia. Podręcznik dla studentów i lekarzy. Kordek R (ed). Via Medica, Gdańsk 2007; 2-114.
 
14.
Europejski kodeks walki z rakiem. Zatoński W (ed). Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Warsaw 2009; 17-95.
 
15.
Mańczuk M. Oszacowanie liczby zgonów nowotworowych wynikających z palenia tytoniu w Polsce. Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Warsaw 2012.
 
16.
Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2009 roku. Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Warsaw 2008; 13-19.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top